A COMPARATIVE STUDY OF PROFITABILITY OF SELECTED PHARMA COMPANIES OF INDIA

CA Brijesh H. Vithalani; Dr. Prashant M. Joshi

Volume : V, Issue : VI, June - 2016

A COMPARATIVE STUDY OF PROFITABILITY OF SELECTED PHARMA COMPANIES OF INDIA

Ca Brijesh H. Vithalani, Dr. Prashant M. Joshi

Abstract :

 The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. The pharmaceutical industry in India meets around 70% of the country�s demand for bulk drugs, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectable. There are two major things coming out, firstly, Indian Pharmaceutical Industry is growing in output, value, volume, number of units - steadily and showing resemblance to the entire growth story of Indian Economy. Secondly, there is a major change occurring to the very basic system of pharmaceutical business in India. By issuing the patent ordinance, India met a WTO commitment to recognize foreign product patents from 1st January 2005, the culmination of 10 year process. In this new scenario, the Indian Pharmaceutical manufacturers would not be able to manufacture patented drugs which they have been doing since long although by another process. This study has been undertaken for critical assessment of pharmaceutical industry of India. The study period is of ten years from 2004-05 to 2013- 14 to analyse the profitability performance of leading pharmaceutical companies and comparison amongst them.